Measles Virus Defective Interfering RNAs Are Generated Frequently and Early in the Absence of C Protein and Can Be Destabilized by Adenosine Deaminase Acting on RNA-1-Like Hypermutations
Overview
Authors
Affiliations
Unlabelled: Defective interfering RNAs (DI-RNAs) of the viral genome can form during infections of negative-strand RNA viruses and outgrow full-length viral genomes, thereby modulating the severity and duration of infection. Here we document the frequent de novo generation of copy-back DI-RNAs from independent rescue events both for a vaccine measles virus (vac2) and for a wild-type measles virus (IC323) as early as passage 1 after virus rescue. Moreover, vaccine and wild-type C-protein-deficient (C-protein-knockout [CKO]) measles viruses generated about 10 times more DI-RNAs than parental virus, suggesting that C enhances the processivity of the viral polymerase. We obtained the nucleotide sequences of 65 individual DI-RNAs, identified breakpoints and reinitiation sites, and predicted their structural features. Several DI-RNAs possessed clusters of A-to-G or U-to-C transitions. Sequences flanking these mutation sites were characteristic of those favored by adenosine deaminase acting on RNA-1 (ADAR1), which catalyzes in double-stranded RNA the C-6 deamination of adenosine to produce inosine, which is recognized as guanosine, a process known as A-to-I RNA editing. In individual DI-RNAs the transitions were of the same type and occurred on both sides of the breakpoint. These patterns of mutations suggest that ADAR1 edits unencapsidated DI-RNAs that form double-strand RNA structures. Encapsidated DI-RNAs were incorporated into virus particles, which reduced the infectivity of virus stocks. The CKO phenotype was dominant: DI-RNAs derived from vac2 with a CKO suppressed the replication of vac2, as shown by coinfections of interferon-incompetent lymphatic cells with viruses expressing different fluorescent reporter proteins. In contrast, coinfection with a C-protein-expressing virus did not counteract the suppressive phenotype of DI-RNAs.
Importance: Recombinant measles viruses (MVs) are in clinical trials as cancer therapeutics and as vectored vaccines for HIV-AIDS and other infectious diseases. The efficacy of MV-based vectors depends on their replication proficiency and immune activation capacity. Here we document that copy-back defective interfering RNAs (DI-RNAs) are generated by recombinant vaccine and wild-type MVs immediately after rescue. The MV C protein interferes with DI-RNA generation and may enhance the processivity of the viral polymerase. We frequently detected clusters of A-to-G or U-to-C transitions and noted that sequences flanking individual mutations contain motifs favoring recognition by the adenosine deaminase acting on RNA-1 (ADAR1). The consistent type of transitions on the DI-RNAs indicates that these are direct substrates for editing by ADAR1. The ADAR1-mediated biased hypermutation events are consistent with the protein kinase R (PKR)-ADAR1 balancing model of innate immunity activation. We show by coinfection that the C-defective phenotype is dominant.
Ribo-Molina P, Groen K, Susma B, van Nieuwkoop S, Funk M, Fouchier R J Virol. 2025; 99(2):e0124324.
PMID: 39835813 PMC: 11852930. DOI: 10.1128/jvi.01243-24.
Taye B, Yousaf I, Navaratnarajah C, Schroeder D, Pfaller C, Cattaneo R J Virol. 2024; 98(11):e0123224.
PMID: 39431848 PMC: 11575405. DOI: 10.1128/jvi.01232-24.
Immunological landscape of human lymphoid explants during measles virus infection.
Acklin J, Patel A, Kurland A, Horiuchi S, Moss A, DeGrace E JCI Insight. 2024; 9(17).
PMID: 39253971 PMC: 11385098. DOI: 10.1172/jci.insight.172261.
BenDavid E, Yang C, Zhou Y, Pfaller C, Samuel C, Ma D J Virol. 2024; 98(9):e0102024.
PMID: 39194235 PMC: 11406981. DOI: 10.1128/jvi.01020-24.
Asuelime-Smith M, Ma D Methods Mol Biol. 2024; 2808:129-140.
PMID: 38743367 DOI: 10.1007/978-1-0716-3870-5_10.